Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Frontiers in Molecular Biosciences|July 8, 2026
Evaluation of HER2 status and characteristics by next-generation sequencing in breast cancerNanqiu Liu, Chongyang Ren, Yongqi Ren, et al.
Breast Cancer (Tokyo, Japan)|January 2, 2021
PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencingMinghan Jia, Ning Liao, Bo Chen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 10, 2004
[Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro]Zhi-qiang Han, A-li Zhang, Ming-fu Wu, et al.
Food & Function|January 17, 2025
Dietary limonin alleviates Salmonella Typhimurium-induced colitis via dual targeting virulence SopB and SopE2 and inhibiting RAC1/CDC42/Arp2/3 pathway and regulating gut microbiotaXinhua Cui, Yang Wang, Jiajia Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2023
Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study)Jiayu Wang, Li Cai, Yanqiu Song, et al.
Food & Function|February 3, 2025
Genistein alleviates rheumatoid arthritis by inhibiting fibroblast-like synovial exosome secretion regulated by the Rab27/nSMase2/Mfge8 pathwayJiaJia Liu, Jinyang Shi, Sijia Niu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 30, 2024
Ginsenoside Ro improves Salmonella Typhimurium-induced colitis through inhibition of the virulence factors SopB and SopE2 via the RAC1/CDC42/ARP2/3 pathwayXinhua Cui, Yang Wang, Ziyan Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|January 12, 2005
[Effects of chemokine receptor and its ligand on migration of ovarian cancer cells]Fang Li, Huai-Shi Zhu, Zhi-Qiang Han, et al.
BMC Medicine|April 28, 2022
Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 statusGuochun Zhang, Chongyang Ren, Cheukfai Li, et al.
Acta Pharmacologica Sinica|January 13, 2023
Computationally guided discovery of novel non-steroidal AR-GR dual antagonists demonstrating potency against antiandrogen resistanceXin Chai, Xue-Ping Hu, Xin-Yue Wang, et al.
Pageof 18